Theralase Inc.
Theralase Inc. has 6 FDA enforcement events on this register (7 product records) between 2019 and 2019: 6 device; the busiest year was 2019 with 6.
0% of its events are Class I; the most common class is Class III (6). 0 events are listed as ongoing; the recalling firm's address is in N/A.
Recall classification reflects the relative degree of health hazard. Event counts depend on a firm's size and product range; they are not a comparison of one firm with another.
Enforcement events
| Initiated | Product (first record) | Type | Class | Records | Status |
|---|---|---|---|---|---|
| 26 Sep 2019 | TLC-2000 Therapeutic Medical Laser System - Product Usage: Indicated for the temporary relief of knee pain. | Device | Class III | 1 | Terminated |
| 26 Sep 2019 | TLC-2000 Therapeutic Medical Laser System | Device | Class III | 1 | Terminated |
| 26 Sep 2019 | TLC-2000 Therapeutic Medical Laser System | Device | Class III | 1 | Terminated |
| 26 Sep 2019 | TLC-2000 Therapeutic Medical Laser System Power Pack, Model Number TLC-2002 | Device | Class III | 1 | Terminated |
| 26 Sep 2019 | TLC-2000 Therapeutic Medical Laser System, used for the temporary relief of knee pain. | Device | Class III | 2 | Terminated |
| 26 Sep 2019 | TLC-2000 Therapeutic Medical Laser System | Device | Class III | 1 | Terminated |
By type and class
Class I: 0% of this firm's events; 18% of all events on the register.
Events by year
Questions and answers
How many FDA recalls has Theralase Inc. had?
6 enforcement events (7 product records) on this register, 2019–2019: 6 device.
Are any Theralase Inc. recalls ongoing?
0 events are listed as ongoing in the current openFDA export.
What class are Theralase Inc. recalls?
6 Class III. 0% are Class I against 18% of all events on the register. Class reflects the relative degree of health hazard of the product, not the firm.
Where does this data come from?
openFDA food, drug and device enforcement reports (CC0), export dated 28 Sep 2026.
Provenance
Source: openFDA enforcement reports (CC0), export dated 28 Sep 2026. Firm names are grouped exactly as FDA spells them; the same company can appear under several spellings. Only organisations are shown. See the methodology.